布地奈德雾化吸入治疗毛细支气管炎疗效分析

目的：探讨布地奈德雾化吸入治疗毛细支气管炎的临床疗效。方法随机选取2015年1月―2016年1月江苏省沛县人民医院儿科毛细支气管炎住院患儿60例,随机分成两组,对照组30例给予常规治疗,治疗组30例在常规治疗的基础上加用吸入用布地奈德混悬液雾化吸入,观察两组患儿主要临床症状、体征消失时间及住院天数。结果治疗组与对照组的憋喘时间分别为(5.0±0.5)d与(6.2±0.4)d；肺部哮鸣音消失时间分别为(5.8±0.3)d与(6.8±0.2)d；住院天数分别为(7.0±0.4)d与(7.9±0.6)d,两组差异均有统计学意义(P<0.05﹚。结论布地奈德雾化吸入治疗毛细支气管炎可使临床症状体征缓解,病程缩短,疗效确切,安全性好,值得临床推广。

Budesonide Inhalation Treatment of Bronchiolitis

Objective To observe the clinical efficacy of nebulized budesonide inhalation in treatment of bronchiolitis. Methods Random selection January 2015 ― January 2016 Pei County, Jiangsu Province People's Hospital pediatric bron-chiolitis hospitalized children 60 cases were randomly divided into two groups, the control group (30 cases) given conven-tional treatment, treatment group (30 cases) on the basis of conventional treatment combined with inhalation with budesonide suspension liquid atomization inhalation, observe two groups of children with main clinical symptoms and signs disappeared time and length of hospital stay. Results In the treatment group and control group in the breath holding time was (5.0±0.5)d and (6.2±0.4)d;wheezing stridor disappeared time (5.8±0.3)d and (6.8±0.2)d, respectively;and length of stay were(7.0±0.4)d and (7.9±0.6)d, the difference between the two groups were statistically significant (P<0.05). Conclusion Budesonide atom-ization inhalation treatment of bronchiolitis can relieve the clinical signs and symptoms, shorten the course of disease, cura-tive effect, good security, it is worth clinical promotion.